+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID06658002

Study of Cyclosporine A Eye Drops with Natamycin for Treating Fungal Corneal Ulcers

Led by University of California, San Francisco · Updated on 2026-06-05

150

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether adding topical Cyclosporine A eye drops to standard treatment with Natamycin improves vision outcomes in patients with fungal keratitis, an infection of the cornea. This randomized, masked clinical trial compares low-dose 0.1% and higher-dose 2% Cyclosporine A against a placebo to see which works best as an additional therapy. The study aims to find out if early use of Cyclosporine A benefits mild to moderate fungal keratitis and which ulcer features predict the most improvement. Participants with confirmed fungal keratitis receive topical Natamycin drops for at least 48 hours. Then they are randomly assigned to one of three groups Cyclosporine A 0.1%, Cyclosporine A 2%, or placebo for four weeks. Natamycin treatment continues until the corneal ulcer has healed. The drops are used four times a day for one month, then twice daily for another month. This trial is conducted with cornea specialists at a hospital where fungal keratitis is common. Participants will have their best corrected vision tested at 12 weeks as the primary outcome. Other assessments include measuring corneal scar size, checking for corneal perforation, tracking ulcer healing, and confirming microbiologic cure. The study involves regular follow-ups to monitor healing and safety. Overall participation spans about three months, during which vision and eye health are carefully evaluated to understand the effects of the treatments.

CONDITIONS

Brief Title

Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A

Research Team

G

Gerami D Seitzman, MD

T

Thomas Lietman, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here